Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 10 Zidovudine 9 Vincristine 7 Bleomycin 7 Nivolumab 6 Liposomes 5 Interferon alpha-2 5 Etoposide 5 tecogalan 4 pembrolizumab 4 liposomal doxorubicin 4 Valganciclovir 4 Specimen Handling 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Magnetic Resonance Spectroscopy 4 pomalidomide 3 Ritonavir 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × Emtricitabine × Clear all

NCT00444379 2014-08-20

ARKS

University of California, San Francisco

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡